Innocoll Drug Patent Portfolio
Innocoll owns 1 orange book drug protected by 6 US patents Given below is the list of Innocoll's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11400019 | Sustained release drug delivery systems with reduced impurities and related methods | 12 Jan, 2041 | Active |
| US11771624 | Sustained release drug delivery systems with reduced impurities and related methods | 12 Jan, 2041 | Active |
| US8153149 | Controlled delivery system | 15 Sep, 2025 | Active |
| US8153661 | Controlled delivery system | 15 Sep, 2025 | Active |
| US8753665 | Controlled delivery system | 15 Sep, 2025 | Active |
| US8846072 | Controlled delivery system | 15 Sep, 2025 | Active |
Latest Legal Activities on Innocoll's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Innocoll.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Post Issue Communication - Certificate of Correction | 13 Oct, 2023 | US11400019 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 10 Oct, 2023 | US8153149 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 10 Oct, 2023 | US8153661 |
|
Email Notification
Critical
| 03 Oct, 2023 | US11771624 |
| Recordation of Patent eGrant | 03 Oct, 2023 | US11771624 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 03 Oct, 2023 | US11771624 |
| Patent eGrant Notification | 03 Oct, 2023 | US11771624 |
| Mail Patent eGrant Notification | 03 Oct, 2023 | US11771624 |
|
Recordation of Patent Grant Mailed
Critical
| 03 Oct, 2023 | US11771624 |
|
Email Notification
Critical
| 15 Sep, 2023 | US11771624 |
|
Issue Notification Mailed
Critical
| 13 Sep, 2023 | US11771624 |
|
Application Is Considered Ready for Issue
Critical
| 18 Aug, 2023 | US11771624 |
| Dispatch to FDC | 18 Aug, 2023 | US11771624 |
|
Issue Fee Payment Verified
Critical
| 17 Aug, 2023 | US11771624 |
|
Issue Fee Payment Received
Critical
| 17 Aug, 2023 | US11771624 |
Innocoll's Family Patents
Innocoll Drug List
Given below is the complete list of Innocoll's drugs and the patents protecting them.
1. Posimir
Posimir is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11400019 | Sustained release drug delivery systems with reduced impurities and related methods |
12 Jan, 2041
(16 years from now)
| Active |
| US11771624 | Sustained release drug delivery systems with reduced impurities and related methods |
12 Jan, 2041
(16 years from now)
| Active |
| US8153149 | Controlled delivery system |
15 Sep, 2025
(9 months from now)
| Active |
| US8153661 | Controlled delivery system |
15 Sep, 2025
(9 months from now)
| Active |
| US8753665 | Controlled delivery system |
15 Sep, 2025
(9 months from now)
| Active |
| US8846072 | Controlled delivery system |
15 Sep, 2025
(9 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Posimir's drug page